Gene Therapy and Genome Project - Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Gene Therapy

Genome Project

Exa-Cel CRISPR Gene Therapy for Sickle Cell Disease Deemed Safe by FDA Advisory Panel

XTalks

NOVEMBER 3, 2023

After spending almost an entire day deliberating the safety of Vertex Pharmaceuticals’ and CRISPR Therapeutics’ CRISPR-based gene therapy exa-cel for sickle cell disease, a US Food and Drug Administration (FDA) advisory panel appears to be satisfied with what it saw.

Gene Therapy

Gene Therapy Gene Gene Editing In-Vivo

Can genetic data be a magic bullet for drug R&D?

pharmaphorum

JANUARY 24, 2023

Pharma has used this to begin creating targeted treatments, such as gene therapies , which are able to hone in on gene mutations that cause health issues and eradicate or replace the faulty gene. The information gathered from the project is still providing insights today, a decade later.

Genetics

Genetics Drugs Genome Project Biobanking

The Biotech Effect

Pharmaceutical Technology

AUGUST 26, 2008

“However, around the time of the Human Genome Project, there was a ‘land grab’ for the new technologies as big pharmaceuticals tried to catch up paying high prices to access technology platforms in areas such as genomics and high throughput screening.”

Antibody

Antibody Licensing Licensing Production

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Exa-Cel CRISPR Gene Therapy for Sickle Cell Disease Deemed Safe by FDA Advisory Panel

Can genetic data be a magic bullet for drug R&D?

The Biotech Effect

Webinars

Stay Connected